Observational Study With InnoLet® in Daily Clinical Practice

A Prospective, Open, Uncontrolled, Observational Study With Innolet in Daily Clinical Situations According to the Product Labelling, Without Any Study Specific Investigations

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01492959

Enrollment

1030

Registered

2011-12-15

Start date

2004-03-23

Completion date

2005-03-23

Last updated

2017-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Asia. The aim of this study is to review the efficacy and safety of insulin treatment with InnoLet® in daily clinical practice.

Interventions

DRUGinsulin human

Insulin human delivered with the InnoLet® device was prescribed according to product labelling to subjects in need of insulin treatment

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diabetes mellitus (Type 1 or type 2) * Need insulin treatment

Design outcomes

Primary

Measure	Time frame
Change in HbA1c (glycosylated haemoglobin)	—

Secondary

Measure	Time frame
Adverse events: Serious and non-serious	—

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026